Skip to main content

Table 2 Clinicopathological characteristics of patients with high and low nodal burden

From: Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients

Characteristics

Low nodal burden

(n = 293)

High nodal burden

(n = 19)

P value

Age

  

.478

  ≤ 50 years

145 (92.9%)

11 (7.1%)

 

  > 50 years

148 (94.9%)

8 (5.1%)

 

Pathological T stage

  

<.001

 T1

229 (97.0%)

7 (3.0%)

 

  ≥ T2

64 (84.2%)

12 (15.8%)

 

Histologic type

  

.220

 Invasive ductal

269 (93.4%)

19 (6.6%)

 

 Invasive lobular

12 (100.0%)

0

 

 Othersa

12 (100.0%)

0

 

Tumor focality

  

.544

 Unifocal

233 (94.3%)

14 (5.7%)

 

 Multifocal/multicentric

60 (92.3%)

5 (7.7%)

 

Tumor location

  

.175

 Upper outer

138 (92.0%)

12 (8.0%)

 

 Othersb

155 (95.7%)

7 (4.3%)

 

Histologic grade

  

.438

 Low

32 (97.0%)

1 (3.0%)

 

 Moderate or High

261 (93.5%)

18 (6.5%)

 

HR status

  

.468

 Negative

57 (91.9%)

5 (8.1%)

 

 Positive

236 (94.4%)

14 (5.6%)

 

HER2 status c

  

.759

 Negative

217 (93.5%)

15 (6.5%)

 

 Positive

53 (94.6%)

3 (5.4%)

 
  1. HR hormone receptor, HER2 human epidermal growth factor receptor 2
  2. aOthers include mucinous cancer (n = 10) and metaplastic cancer (n = 2)
  3. bOther include upper inner, lower inner, lower outer, and subareolar
  4. cHER2 status was available only in 288 patients